A New Modality for Breast Cancer Diagnosis During the COVID-19 Pandemic: A Case Report.
Fiche publication
Date publication
janvier 2022
Journal
European journal of breast health
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MATHELIN Carole, Dr AME Shanti
Tous les auteurs :
Vibert F, Martel C, Ionescu RA, Mathelin C, Ame S
Lien Pubmed
Résumé
Organized screening for breast cancer (BC) was suspended in most countries of the world during the coronavirus disease-2019 (COVID-19) pandemic. Com-puted tomography (CT) scans of the chest, frequently performed in patients with severe forms of COVID-19, may detect asymptomatic breast abnormalities. A 72-year-old patient, with a severe form of COVID-19 underwent a diagnostic CT scan. This led to the unexpected discovery, at an early stage, of a 12 mm, high grade, Human epidermal growth factor receptor 2 positive BC, with a high proliferation index. After responding to chemotherapy, she was managed with conser-vative breast surgery with sentinel lymph node biopsy. Delayed management of BC can be responsible for poor outcomes. Patients with severe forms of COVID-19 are also at risk for developing BC due to common risk factors. Thirty percent of incidental breast lesions discovered on CT scans are undiagnosed BC. Careful study of the mammary glands on CT scan of patients with COVID-19 may allow early diagnosis of a malignant tumor in a high-risk population for BC and deprived of routine screening mammography.
Mots clés
Breast cancer, COVID-19, SARS-CoV-2, chest scan, screening
Référence
Eur J Breast Health. 2022 Jan;18(1):91-93